The Journal of Immunology, Vol 150, Issue 10 4346-4353, Copyright © 1993 by American Association of Immunologists

ARTICLES

Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1

R Winzen, D Wallach, O Kemper, K Resch and H Holtmann
Institute of Molecular Pharmacology, Medical School, Hannover, Germany.

In cells of the fibroblastoid line SV-80, rapid down-modulation of TNF binding in response to TNF itself, or to IL-1, was followed by a gradual recovery of binding, which occurred even in the continuous presence of the cytokines. Untreated cells carried mainly the 55-kDa receptor species. In cells treated with TNF or IL-1, the 55-kDa TNF-R, although increasing after initial down-modulation, remained lower than before treatment. Expression of the 75-kDa TNF-R species upon treatment with either cytokine was markedly increased. Both TNF and IL-1 also induced a strong increase of the mRNA for the 75-kDa receptors, whereas the amount of mRNA for the 55-kDa receptors decreased. The effects of TNF on cell surface expression of the TNF-R could not be blocked with antibodies to IL-1, nor could the effects of IL-1 be blocked with antibodies to TNF, indicating that each cytokine affects the cell surface expression of the receptors independently of the other. Applying both cytokines together resulted in much stronger increase in expression of the 75-kDa TNF-R than applying each alone. Similar changes in cell surface expression and mRNA levels of the two TNF-R as observed in SV-80 cells were also found in TNF and IL-1-treated human foreskin fibroblasts. It is suggested that these sustained changes in the pattern of receptor expression contribute to the adjustment of the cellular response to TNF when formation of TNF and IL-1 takes place over a prolonged period.

This article has been cited by other articles:

				J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]

				B. Peral, J. L. San Millan, R. Castello, P. Moghetti, and H. F. Escobar-Morreale The Methionine 196 Arginine Polymorphism in Exon 6 of the TNF Receptor 2 Gene (TNFRSF1B) Is Associated with the Polycystic Ovary Syndrome and Hyperandrogenism J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3977 - 3983. [Abstract] [Full Text] [PDF]

				J. Prange-Kiel, C. Kreutzkamm, U. Wehrenberg, and G. M. Rune Role of Tumor Necrosis Factor in Preovulatory Follicles of Swine Biol Reprod, September 1, 2001; 65(3): 928 - 935. [Abstract] [Full Text] [PDF]

				J. Reddy, P. Chastagner, L. Fiette, X. Liu, and J. Theze IL-2-induced tumor necrosis factor (TNF)-{beta} expression: further analysis in the IL-2 knockout model, and comparison with TNF-{{alpha}}, lymphotoxin-{beta}, TNFR1 and TNFR2 modulation Int. Immunol., February 1, 2001; 13(2): 135 - 147. [Abstract] [Full Text] [PDF]

				T. Rönnemaa, K. Pulkki, and J. Kaprio Serum Soluble Tumor Necrosis Factor-{alpha} Receptor 2 Is Elevated in Obesity But Is Not Related to Insulin Sensitivity: A Study in Identical Twins Discordant for Obesity J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2728 - 2732. [Abstract] [Full Text]

				S. Tinkle and L. Newman Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease Am. J. Respir. Crit. Care Med., December 1, 1997; 156(6): 1884 - 1891. [Abstract] [Full Text]

				S. M. Santee and L. B. Owen-Schaub Human Tumor Necrosis Factor Receptor p75/80 (CD120b) Gene Structure and Promoter Characterization J. Biol. Chem., August 30, 1996; 271(35): 21151 - 21159. [Abstract] [Full Text] [PDF]

				R. Winzen, S. Kafert, B. P. H. A. Mylius-Spencker, K. Resch, and H. Holtmann Interaction between the mRNA of the 55-kDa Tumor Necrosis Factor Receptor and Cellular Proteins. POSSIBLE INVOLVEMENT IN POST-TRANSCRIPTIONAL REGULATION OF RECEPTOR EXPRESSION J. Biol. Chem., June 7, 1996; 271(23): 13461 - 13467. [Abstract] [Full Text] [PDF]